Institut de la Vision, Sorbonne Université, INSERM, CNRS, 75012 Paris, France.
Ophthalmology Department, Pitié Salpêtrière University Hospital, Sorbonne Université, AP-HP, 75013 Paris, France.
Int J Mol Sci. 2022 Jan 8;23(2):681. doi: 10.3390/ijms23020681.
Hypoxia is potentially one of the essential triggers in the pathogenesis of wet age-related macular degeneration (wetAMD), characterized by choroidal neovascularization (CNV) which is driven by the accumulation of subretinal mononuclear phagocytes (MP) that include monocyte-derived cells. Here we show that systemic hypoxia (10% O) increased subretinal MP infiltration and inhibited inflammation resolution after laser-induced subretinal injury in vivo. Accordingly, hypoxic (2% O) human monocytes (Mo) resisted elimination by RPE cells in co-culture. In Mos from hypoxic mice, Thrombospondin 1 mRNA (Thbs1) was most downregulated compared to normoxic animals and hypoxia repressed Thbs-1 expression in human monocytes in vitro. Hypoxic ambient air inhibited MP clearance during the resolution phase of laser-injury in wildtype animals, but had no effect on the exaggerated subretinal MP infiltration observed in normoxic Thbs1-mice. Recombinant Thrombospondin 1 protein (TSP-1) completely reversed the pathogenic effect of hypoxia in Thbs1-mice, and accelerated inflammation resolution and inhibited CNV in wildtype mice. Together, our results demonstrate that systemic hypoxia disturbs TSP-1-dependent subretinal immune suppression and promotes pathogenic subretinal inflammation and can be therapeutically countered by local recombinant TSP-1.
缺氧可能是湿性年龄相关性黄斑变性(wAMD)发病机制中的一个关键触发因素,其特征是脉络膜新生血管(CNV),由视网膜下单核吞噬细胞(MP)的积累驱动,包括单核细胞衍生的细胞。在这里,我们表明,全身缺氧(10% O)增加了视网膜下 MP 的浸润,并抑制了体内激光诱导的视网膜下损伤后的炎症消退。因此,在共培养中,缺氧(2% O)人单核细胞(Mo)抵抗 RPE 细胞的消除。与正常氧动物相比,缺氧小鼠的 Thrombospondin 1 mRNA(Thbs1)下调最为明显,体外缺氧抑制人单核细胞中 Thbs-1 的表达。缺氧环境空气抑制了野生型动物激光损伤缓解期的 MP 清除,但对正常氧 Thbs1-小鼠观察到的过度视网膜下 MP 浸润没有影响。重组 Thrombospondin 1 蛋白(TSP-1)完全逆转了 Thbs1-小鼠缺氧的致病作用,并加速了炎症消退,抑制了野生型小鼠的 CNV。总之,我们的结果表明,全身缺氧扰乱了 TSP-1 依赖性视网膜下免疫抑制,并促进了致病的视网膜下炎症,局部重组 TSP-1 可对此进行治疗。